$BYLT
Elite Performance Holding Corp

2024 Q4 Form 10-Q Financial Statement

#000147793224007448 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $275.0K
YoY Change -25.64%
Operating Profit -$275.0K
YoY Change -25.6%
Interest Expense $86.07K
YoY Change 110.98%
% of Operating Profit
Other Income/Expense, Net -$83.37K
YoY Change 172.38%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$358.3K
YoY Change -10.46%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 109.5M shares 109.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $94.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $25.76K
Prepaid Expenses $22.27K
Receivables
Other Receivables
Total Short-Term Assets $48.12K
YoY Change -66.38%
LONG-TERM ASSETS
Property, Plant & Equipment $30.26K
YoY Change -26.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $114.2K
YoY Change -25.65%
TOTAL ASSETS
Total Short-Term Assets $48.12K
Total Long-Term Assets $114.2K
Total Assets $162.3K
YoY Change -45.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $944.6K
YoY Change 9.89%
Accrued Expenses $290.8K
YoY Change -20.55%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.345M
YoY Change 19.16%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.345M
Total Long-Term Liabilities
Total Liabilities $3.502M
YoY Change 17.15%
SHAREHOLDERS EQUITY
Retained Earnings -$9.880M
YoY Change 16.52%
Common Stock $12.76K
YoY Change -1.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.340M
YoY Change
Total Liabilities & Shareholders Equity $162.3K
YoY Change -45.3%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$358.3K
YoY Change -10.46%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52 usd
us-gaap Legal Fees
LegalFees
206406 usd
CY2024Q3 us-gaap Advertising Expense
AdvertisingExpense
11982 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
21251 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38484 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
101400 usd
CY2023Q4 us-gaap Assets
Assets
170738 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
879943 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
397112 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19064 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
820250 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2964683 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
76930 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
95485 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3137098 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13040 usd
CY2023Q4 elite Shares To Be Issued
SharesToBeIssued
50000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5759788 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8790188 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2966360 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
170738 usd
us-gaap Revenues
Revenues
681 usd
us-gaap Revenues
Revenues
40141 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5560 usd
us-gaap Gross Profit
GrossProfit
-3335 usd
us-gaap Legal Fees
LegalFees
210530 usd
elite Consulting Expense
ConsultingExpense
357573 usd
elite Consulting Expense
ConsultingExpense
372724 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
323493 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
387829 usd
us-gaap Operating Expenses
OperatingExpenses
912075 usd
us-gaap Operating Expenses
OperatingExpenses
1030421 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-916954 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
30802 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
30854 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
83934 usd
CY2024Q3 us-gaap Assets
Assets
162311 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
944575 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
290802 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
22268 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3345115 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
61240 usd
CY2024Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
95485 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3501840 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43476 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
166 usd
us-gaap Gross Profit
GrossProfit
-4879 usd
CY2024Q3 us-gaap Legal Fees
LegalFees
99029 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1033756 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
25761 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
30802 usd
CY2024Q3 us-gaap Convertible Debt
ConvertibleDebt
1345495 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
12763 usd
CY2024Q3 elite Shares To Be Issued
SharesToBeIssued
50000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6476849 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9880141 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3339529 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
162311 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
13433 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q3 us-gaap Legal Fees
LegalFees
65765 usd
CY2024Q3 elite Consulting Expense
ConsultingExpense
63156 usd
CY2023Q3 elite Consulting Expense
ConsultingExpense
140900 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
100783 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
141815 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
274950 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
369731 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-274950 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-369565 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
48120 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-83372 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-358322 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
25761 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109081270 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
us-gaap Advertising Expense
AdvertisingExpense
63462 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
50000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
130397550 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001753681
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109081270 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
130397550 shares
CY2023Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55987
dei Entity Registrant Name
EntityRegistrantName
Elite Performance Holding Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5034226
dei Entity Address Address Line1
EntityAddressAddressLine1
3301 NE 1st Ave Suite M704
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
dei City Area Code
CityAreaCode
844
dei Local Phone Number
LocalPhoneNumber
426-2958
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
109481270 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
25761 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
22265 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30257 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
712475 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
633314 usd
CY2024Q3 elite Advance From Customer
AdvanceFromCustomer
29500 usd
CY2023Q4 elite Advance From Customer
AdvanceFromCustomer
215000 usd
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1345495 usd
CY2024Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
156725 usd
CY2023Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
172415 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13267 usd
us-gaap Advertising Expense
AdvertisingExpense
20479 usd
CY2024Q3 us-gaap Other Income
OtherIncome
2700 usd
CY2023Q3 us-gaap Other Income
OtherIncome
10188 usd
us-gaap Other Income
OtherIncome
4945 usd
us-gaap Other Income
OtherIncome
10188 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
86072 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
40797 usd
us-gaap Interest Expense
InterestExpense
177944 usd
us-gaap Interest Expense
InterestExpense
113666 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30609 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-172999 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-103478 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-400174 usd
us-gaap Net Income Loss
NetIncomeLoss
-1089953 usd
us-gaap Net Income Loss
NetIncomeLoss
-1137234 usd
CY2024Q3 elite Earnings Per Share Basic And Diluted Net Loss Per Common Share
EarningsPerShareBasicAndDilutedNetLossPerCommonShare
-0.00
CY2023Q3 elite Earnings Per Share Basic And Diluted Net Loss Per Common Share
EarningsPerShareBasicAndDilutedNetLossPerCommonShare
-0.00
elite Earnings Per Share Basic And Diluted Net Loss Per Common Share
EarningsPerShareBasicAndDilutedNetLossPerCommonShare
-0.01
elite Earnings Per Share Basic And Diluted Net Loss Per Common Share
EarningsPerShareBasicAndDilutedNetLossPerCommonShare
-0.01
CY2024Q3 elite Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
109110083 shares
CY2023Q3 elite Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
129758257 shares
elite Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
113116443 shares
elite Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
128996245 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2966360 usd
CY2024Q1 elite Shares To Be Issued For Services Amount
SharesToBeIssuedForServicesAmount
86000 usd
CY2024Q1 elite Retirement Of Founder Shares Amount
RetirementOfFounderSharesAmount
0 usd
CY2024Q1 elite Warrants Issued For Services
WarrantsIssuedForServices
77623 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
35000 usd
CY2024Q1 elite Shares Issued As Debt Issuance Cost Amount
SharesIssuedAsDebtIssuanceCostAmount
5000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-496619 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-3259356 usd
CY2024Q2 elite Shares To Be Issued For Services Amount
SharesToBeIssuedForServicesAmount
12000 usd
CY2024Q2 elite Warrants Issued For Services
WarrantsIssuedForServices
15884 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
456786 usd
CY2024Q2 elite Shares Issued As Ap Amount
SharesIssuedAsApAmount
4500 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-235012 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-3005198 usd
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4000 usd
CY2024Q3 elite Warrants Issued For Services
WarrantsIssuedForServices
9991 usd
CY2024Q3 elite Shares Issued As Ap Amount
SharesIssuedAsApAmount
10000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-358322 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3339529 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1805214 usd
CY2023Q1 elite Common Shares To Be Issued For Subscriptions Amount
CommonSharesToBeIssuedForSubscriptionsAmount
69000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-363959 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2084173 usd
CY2023Q2 elite Reg D Subscriptions Amount
RegDSubscriptionsAmount
13000 usd
CY2023Q2 elite Shares To Be Issued Fro Reg D Subscriptions
SharesToBeIssuedFroRegDSubscriptions
-9000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
60000 usd
CY2023Q2 elite Shares To Be Issued For Services Amount
SharesToBeIssuedForServicesAmount
-10000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
35000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-373101 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2368274 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
66000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
10000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-400174 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-2692448 usd
elite Profit And Loss
ProfitAndLoss
1089953 usd
elite Profit And Loss
ProfitAndLoss
1137234 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
42029 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
23888 usd
elite Adjustment Of Stock Issued During Period Value Issued For Services
AdjustmentOfStockIssuedDuringPeriodValueIssuedForServices
-102000 usd
elite Adjustment Of Stock Issued During Period Value Issued For Services
AdjustmentOfStockIssuedDuringPeriodValueIssuedForServices
-132000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
103498 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Depreciation
Depreciation
8227 usd
us-gaap Depreciation
Depreciation
8228 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25202 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5041 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-34873 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
22265 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1951 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-17466 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-18049 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
79161 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
147625 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
167823 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
302900 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-586973 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-442518 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
295000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
580000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
98500 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
42000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
75447 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
747 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
12485 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8275 usd
elite Proceeds From Advances
ProceedsFromAdvances
61500 usd
elite Proceeds From Advances
ProceedsFromAdvances
50000 usd
elite Proceeds From Sale Of Common Stock And Shares To Be Issued
ProceedsFromSaleOfCommonStockAndSharesToBeIssued
0 usd
elite Proceeds From Sale Of Common Stock And Shares To Be Issued
ProceedsFromSaleOfCommonStockAndSharesToBeIssued
73000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
587015 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
433525 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
42 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8993 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8993 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
6580 usd
us-gaap Interest Paid Net
InterestPaidNet
16799 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
491786 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
45000 usd
elite Shares Issued As Debt Issuance Cost
SharesIssuedAsDebtIssuanceCost
5000 usd
elite Shares Issued As Debt Issuance Cost
SharesIssuedAsDebtIssuanceCost
0 usd
CY2024Q3 elite Accumulated Deficit
AccumulatedDeficit
-9880141 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The consolidated financial statements include the operations of the Company and its wholly-owned subsidiary, Elite Beverage International Corp.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">All significant intercompany accounts and transactions have been eliminated in consolidation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s consolidated financial statements are prepared using the accrual method of accounting and are presented in accordance with U.S. Generally Accepted Accounting Principles (GAAP). The Company has elected a calendar year-end.</p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
5041 usd
CY2024Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
22265 usd
CY2023Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
0 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
264715 usd
CY2024Q3 elite Common Stock Convertible Shares Issuable
CommonStockConvertibleSharesIssuable
22546690 shares
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
545250 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
259971 usd
CY2023Q4 elite Common Stock Convertible Shares Issuable
CommonStockConvertibleSharesIssuable
16104420 shares
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Revenues
Revenues
681 usd
us-gaap Revenues
Revenues
40141 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
83934 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
83508 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17579 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18049 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
6580 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
7870 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24743 usd
CY2024Q3 elite Property Plant And Equipments Net
PropertyPlantAndEquipmentsNet
30257 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
8228 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
8228 usd
elite Property Plant And Equipment Estimated Useful Life
PropertyPlantAndEquipmentEstimatedUsefulLife
P5Y
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
130397550 shares
CY2024Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
109081270 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2017Q4 elite Preferred Stock Designated Value
PreferredStockDesignatedValue
1000 usd
CY2020Q2 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
201352 usd
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
239 usd
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
239 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
90000 usd
CY2023 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
75000 usd
CY2022 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
20000 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
20000 usd
CY2021 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
12000 usd
CY2020 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
7500 usd
CY2019 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
2000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
205000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
42000 usd
CY2023Q4 elite Balances Of Advances
BalancesOfAdvances
215000 usd
CY2024Q3 elite Balances Of Advances
BalancesOfAdvances
29500 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
5041 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
25761 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
30802 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
30802 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2024Q4 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
100000 usd
CY2024Q4 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
400000 shares

Files In Submission

Name View Source Status
0001477932-24-007448-index-headers.html Edgar Link pending
0001477932-24-007448-index.html Edgar Link pending
0001477932-24-007448.txt Edgar Link pending
0001477932-24-007448-xbrl.zip Edgar Link pending
elite-20240930.xsd Edgar Link pending
elite_10q.htm Edgar Link pending
elite_10qimg1.jpg Edgar Link pending
elite_ex311.htm Edgar Link pending
elite_ex312.htm Edgar Link pending
elite_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
elite-20240930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elite_10q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
elite-20240930_cal.xml Edgar Link unprocessable
elite-20240930_lab.xml Edgar Link unprocessable
elite-20240930_pre.xml Edgar Link unprocessable